Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 12, 2012. The report details a specific share repurchase transaction executed under authority granted by shareholders at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 510,000 Ordinary Shares of 25 pence each.
- Purchase Date: December 12, 2012.
- Price Range: Highest price paid was 1,378.5 pence per share; lowest price paid was 1,365.0 pence per share.
- Treasury Holdings (Settled): 492,206,327 shares (9.12% of total issued share capital).
- Treasury Holdings (Including Unsettled): 493,851,327 shares (10.07% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,905,029,006 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 510,000 shares for Treasury. This transaction increased the percentage of total voting rights held in Treasury from the prior settled position to 10.07% when including unsettled shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Investor Verification Checklist
- Verify the total number of shares in issue (4,905,029,006) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the current percentage of voting rights held in Treasury (10.07% including unsettled shares).
- Review the price paid per share (1,365.0 to 1,378.5 pence) against market prices on December 12, 2012.
- Note that this filing does not contain operational or financial performance data for the period.